GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Chi Sheng Pharma & Biotech Co Ltd (ROCO:4111) » Definitions » Shiller PE Ratio

Chi Sheng Pharma & Biotech Co (ROCO:4111) Shiller PE Ratio : 16.36 (As of Apr. 26, 2024)


View and export this data going back to 1999. Start your Free Trial

What is Chi Sheng Pharma & Biotech Co Shiller PE Ratio?

As of today (2024-04-26), Chi Sheng Pharma & Biotech Co's current share price is NT$25.85. Chi Sheng Pharma & Biotech Co's E10 for the quarter that ended in Sep. 2023 was NT$1.58. Chi Sheng Pharma & Biotech Co's Shiller PE Ratio for today is 16.36.

The historical rank and industry rank for Chi Sheng Pharma & Biotech Co's Shiller PE Ratio or its related term are showing as below:

ROCO:4111' s Shiller PE Ratio Range Over the Past 10 Years
Min: 15.23   Med: 17.91   Max: 23.96
Current: 16.33

During the past years, Chi Sheng Pharma & Biotech Co's highest Shiller PE Ratio was 23.96. The lowest was 15.23. And the median was 17.91.

ROCO:4111's Shiller PE Ratio is ranked better than
72.73% of 275 companies
in the Medical Devices & Instruments industry
Industry Median: 27.09 vs ROCO:4111: 16.33

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Chi Sheng Pharma & Biotech Co's adjusted earnings per share data for the three months ended in Sep. 2023 was NT$0.380. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is NT$1.58 for the trailing ten years ended in Sep. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Chi Sheng Pharma & Biotech Co Shiller PE Ratio Historical Data

The historical data trend for Chi Sheng Pharma & Biotech Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chi Sheng Pharma & Biotech Co Shiller PE Ratio Chart

Chi Sheng Pharma & Biotech Co Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 20.21 20.11 16.93 17.38

Chi Sheng Pharma & Biotech Co Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.63 17.38 17.93 18.71 16.30

Competitive Comparison of Chi Sheng Pharma & Biotech Co's Shiller PE Ratio

For the Medical Instruments & Supplies subindustry, Chi Sheng Pharma & Biotech Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chi Sheng Pharma & Biotech Co's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Chi Sheng Pharma & Biotech Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Chi Sheng Pharma & Biotech Co's Shiller PE Ratio falls into.



Chi Sheng Pharma & Biotech Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Chi Sheng Pharma & Biotech Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=25.85/1.58
=16.36

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chi Sheng Pharma & Biotech Co's E10 for the quarter that ended in Sep. 2023 is calculated as:

For example, Chi Sheng Pharma & Biotech Co's adjusted earnings per share data for the three months ended in Sep. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Sep. 2023 (Change)*Current CPI (Sep. 2023)
=0.38/129.8595*129.8595
=0.380

Current CPI (Sep. 2023) = 129.8595.

Chi Sheng Pharma & Biotech Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201312 0.596 98.326 0.787
201403 0.365 99.695 0.475
201406 0.375 100.560 0.484
201409 0.490 100.428 0.634
201412 0.050 99.070 0.066
201503 0.110 99.621 0.143
201506 0.220 100.684 0.284
201509 0.320 100.392 0.414
201512 0.020 99.792 0.026
201603 0.160 100.470 0.207
201606 0.290 101.688 0.370
201609 0.370 101.861 0.472
201612 0.450 101.863 0.574
201703 0.380 102.862 0.480
201706 0.340 103.349 0.427
201709 0.420 104.136 0.524
201712 0.280 104.011 0.350
201803 0.170 105.290 0.210
201806 0.180 106.317 0.220
201809 0.280 106.507 0.341
201812 0.110 105.998 0.135
201903 0.240 107.251 0.291
201906 0.370 108.070 0.445
201909 0.290 108.329 0.348
201912 0.370 108.420 0.443
202003 0.450 108.902 0.537
202006 0.280 108.767 0.334
202009 0.140 109.815 0.166
202012 0.150 109.897 0.177
202103 0.220 111.754 0.256
202106 0.210 114.631 0.238
202109 0.390 115.734 0.438
202112 0.590 117.630 0.651
202203 0.460 121.301 0.492
202206 0.460 125.017 0.478
202209 0.820 125.227 0.850
202212 0.950 125.222 0.985
202303 0.330 127.348 0.337
202306 0.360 128.729 0.363
202309 0.380 129.860 0.380

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Chi Sheng Pharma & Biotech Co  (ROCO:4111) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Chi Sheng Pharma & Biotech Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Chi Sheng Pharma & Biotech Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Chi Sheng Pharma & Biotech Co (ROCO:4111) Business Description

Traded in Other Exchanges
N/A
Address
No. 3, Shijian Road, Hsin Chu Industrial Park, Hsinchu County, Hukou, TWN, 30316
Chi Sheng Pharma & Biotech Co Ltd manufactures and distributes medical medicines and equipment in Taiwan. It offers injections, including hemodialysis solutions, amino acid injections, vitamin injections, and externally applied medicines.

Chi Sheng Pharma & Biotech Co (ROCO:4111) Headlines

No Headlines